Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042
- (1)
- References 36 and 38 have mistakenly addressed sPD-L1, instead of sPD-1; relevant references on sPD-1 are: PMIDs 33499013, and 26859684 (Pubmed). In page 19, line 33 from the top, the correct reference is 33.
- (2)
- In flow cytometry, the antibodies used for PD-L1 were “#14-5983-82 (Thermo Fisher Scientific, Waltham, MA, USA), followed by FITC-conjugated #115-095-003 (Jackson ImmunoResearch Laboratories, West Grove, PA, USA)”.
- (3)
- Legend to Figure 4 got corrupted and should be: “The cell-autonomous activities of WT-PD-L1 act via chemokine receptors to upregulate the expression of their corresponding chemokines”.
Reference
- Erlichman, N.; Baram, T.; Meshel, T.; Morein, D.; Da’adoosh, B.; Ben-Baruch, A. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Erlichman, N.; Baram, T.; Meshel, T.; Morein, D.; Da’adoosh, B.; Ben-Baruch, A. Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042. Cancers 2022, 14, 2579. https://doi.org/10.3390/cancers14112579
Erlichman N, Baram T, Meshel T, Morein D, Da’adoosh B, Ben-Baruch A. Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042. Cancers. 2022; 14(11):2579. https://doi.org/10.3390/cancers14112579
Chicago/Turabian StyleErlichman, Nofar, Tamir Baram, Tsipi Meshel, Dina Morein, Benny Da’adoosh, and Adit Ben-Baruch. 2022. "Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042" Cancers 14, no. 11: 2579. https://doi.org/10.3390/cancers14112579
APA StyleErlichman, N., Baram, T., Meshel, T., Morein, D., Da’adoosh, B., & Ben-Baruch, A. (2022). Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042. Cancers, 14(11), 2579. https://doi.org/10.3390/cancers14112579
